Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events: A Randomized Controlled Trial
Article Abstract:
The cholesterol-lowering drug gemfibrozil can lower the risk of heart attack in men with low blood levels of HDL cholesterol, according to a study of 2,531 men. HDL cholesterol is the 'good' cholesterol that can protect people against heart disease.
author: Hershman, Jerome M., Robins, Sander J., Collins, Dorothea, Wittes, Janet T., Papademetriou, Vasilios, Deedwania, Prakash C., Schaefer, Ernst J., McNamara, Judith R., Kashyap, Moti L., Wexler, Laura F., Rubins, Hanna Bloomfield
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
Health aspects
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women
Article Abstract:
The effect of lipids on coronary heart disease on both sexes was studied and results documented.
author: D'Agostino, Ralph B., Schaefer, Ernst J., McNamara, Judith R., Sullivan, Lisa, Wilson, Peter W.F., Vasan, Ramchandran S., Pencina, Michael J., Ingelsson, Erik, Keyes, Michelle J., Contois, John H., Schoonmaker, Christopher
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2007
Science & research, Research, Diagnosis, Risk factors, Coronary heart disease, Lipids, Clinical report
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
Article Abstract:
Gemfibrozil may lower the risk of heart attack, stroke, and death in men with low levels of high-density lipoprotein (HDL) cholesterol without high total cholesterol levels. Researchers administered the cholesterol-lowering drug or a placebo to 2,531 men. After about five years, 17% of the drug-treated men and 22% of the placebo-treated men suffered a heart attack or died -- a 24% reduction in risk due to the drug therapy. Gemfibrozil increased HDL levels and decreased blood triglyceride levels, but did not change low-density lipoprotein (LDL) cholesterol levels.
author: Wilt, Timothy J., Elam, Marshall B., Robins, Sander J., Collins, Dorothea, Schaefer, Ernst J., Rubins, Hanna Bloomfield, Schectman, Gordon, Anderson, James W., Wittes, Janet, Fye, Carol L., Faas, Fred H., Linares, Esteban
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1999
United States, Statistical Data Included, Drug therapy, Cholesterol, LDL, VLDL cholesterol lipoproteins, Stroke (Disease), Stroke, Hypercholesterolemia, Antilipemic agents
subjects list: Evaluation, Prevention, Heart attack, Cholesterol, HDL, HDL cholesterol lipoproteins, Gemfibrozil
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.